Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 9 Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 7 Glioblastoma 7 Colorectal Neoplasms 6 Gliosarcoma 5 Neoplasm Metastasis 4 Colonic Neoplasms 4 Breast Neoplasms 4 Brain Neoplasms 4 Rectal Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Solid Tumor 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Mesothelioma, Malignant 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms, Male 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1

Interventions

Gemcitabine 35 Cisplatin 21 Capecitabine 17 Oxaliplatin 16 Leucovorin 11 Fluorouracil 11 pembrolizumab 8 S 1 (combination) 8 Nivolumab 6 tremelimumab 5 durvalumab 5 Bevacizumab 5 lenvatinib 4 Irinotecan 4 trametinib 3 titanium silicide 3 atezolizumab 3 Radiofrequency Ablation 3 zanidatamab 2 vandetanib 2 irinotecan sucrosofate 2 derazantinib 2 camrelizumab 2 binimetinib 2 apatinib 2 Trastuzumab 2 Tegafur 2 Radiotherapy 2 Panitumumab 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Biliary Tract Neoplasms × cediranib × Clear all

NCT00939848 2014-10-27

ABC-03

University College, London

Phase 2/3 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡